Tudor Investment Corp ET AL purchased a new stake in Varex Imaging Co. (NASDAQ:VREX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 48,452 shares of the company's stock, valued at approximately $707,000. Tudor Investment Corp ET AL owned approximately 0.12% of Varex Imaging at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging during the fourth quarter worth $25,000. Quadrant Capital Group LLC boosted its holdings in shares of Varex Imaging by 115.4% during the 4th quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock valued at $41,000 after acquiring an additional 1,520 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in Varex Imaging during the 4th quarter worth $98,000. US Bancorp DE grew its position in Varex Imaging by 149.8% during the 4th quarter. US Bancorp DE now owns 7,386 shares of the company's stock worth $108,000 after acquiring an additional 4,429 shares during the last quarter. Finally, New York State Common Retirement Fund increased its holdings in Varex Imaging by 60.7% in the 4th quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock worth $139,000 after purchasing an additional 3,600 shares in the last quarter.
Varex Imaging Trading Down 0.7%
Shares of NASDAQ VREX traded down $0.05 during trading on Tuesday, reaching $7.47. The company had a trading volume of 69,965 shares, compared to its average volume of 572,122. Varex Imaging Co. has a 12 month low of $6.76 and a 12 month high of $16.93. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02. The stock has a market cap of $307.76 million, a P/E ratio of -6.38 and a beta of 0.62. The company's fifty day moving average price is $9.76 and its 200-day moving average price is $12.67.
Varex Imaging (NASDAQ:VREX - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. The business had revenue of $212.90 million during the quarter, compared to the consensus estimate of $206.76 million. During the same quarter in the prior year, the firm posted $0.16 EPS. The company's revenue for the quarter was up 3.3% compared to the same quarter last year. As a group, research analysts expect that Varex Imaging Co. will post 0.53 earnings per share for the current year.
Insider Transactions at Varex Imaging
In other Varex Imaging news, SVP Kimberley E. Honeysett sold 4,007 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total value of $51,329.67. Following the completion of the sale, the senior vice president now owns 4,002 shares of the company's stock, valued at approximately $51,265.62. This trade represents a 50.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Sunny Sanyal sold 8,749 shares of the business's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the sale, the chief executive officer now owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. This represents a 4.40% decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on VREX. Oppenheimer cut their price target on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a research note on Friday, February 7th. StockNews.com upgraded shares of Varex Imaging from a "hold" rating to a "buy" rating in a research report on Friday, February 7th. Finally, B. Riley upgraded shares of Varex Imaging to a "strong-buy" rating in a research report on Monday.
View Our Latest Stock Report on VREX
Varex Imaging Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Featured Articles

Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.